In part 4 of our interview, we learn more about nipocalimab’s safety profile and how this investigative agent might address ...

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are ...

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...

J&J IM, which this year marks two decades in Cork, was presented with the award at Cork Chamber’s annual dinner at City Hall ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of some unusual options trading on Thursday. Stock traders purchased 58,414 call options on the stock. This is an increase of ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

Laura Leonetti, Johnson & Johnson Innovative Medicine’s vice president, global commercial leader, dermatology and rheumatology, explains that the company’s approach builds on discoveries about ...

Johnson & Johnson MedTech, the global leader in heart recovery, is proud to celebrate the inaugural National Heart Recovery ...

Truist Financial Corp reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 11.0% during the fourth quarter, ...